Fresenius Kidney Care Longview, LLC
Fresenius Kidney Care Longview, LLC was paid $3.43M by Medicaid between Sep 2019 and Nov 2024, across 40 billing codes. Its largest line is 90999, dialysis (unlisted procedure) — 91% of everything it billed.
LONGVIEW, WA 98632
Next to other End-Stage Renal Disease (ESRD) Treatment Clinic/Center providers in Washington
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 4,429 | $84K | |
| 2020 | 26,421 | $630K | |
| 2021 | 32,562 | $641K | |
| 2022 | 37,534 | $652K | |
| 2023 | 42,898 | $706K | |
| 2024incomplete | 31,618 | $716K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 90999 | Dialysis (unlisted procedure)Unlisted dialysis procedure, inpatient or outpatient | 91% | 40,019 | 2,831 | $3.13M |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 5.3% | 2,958 | 1,725 | $183K |
| A4657 | Syringe, with or without needle, each | 2.7% | 50,040 | 2,293 | $92K |
| J1756 | Injection, iron sucrose, 1 mg | <1% | 7,081 | 1,491 | $15K |
| J0882 | Injection, darbepoetin alfa, 1 microgram (for esrd on dialysis) | <1% | 239 | 94 | $8K |
| 83970 | <1% | 1,426 | 1,184 | $585.99 | |
| J1270 | Injection, doxercalciferol, 1 mcg | <1% | 2,721 | 233 | $289.91 |
| 83550 | <1% | 2,571 | 2,200 | $274.68 | |
| 84520 | <1% | 4,855 | 2,029 | $255.78 | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 2,536 | 2,180 | $237.17 |
| 83540 | <1% | 2,575 | 2,203 | $203.44 | |
| 82310 | <1% | 2,524 | 1,882 | $192.76 |
28 more codes
| 90686 | <1% | 78 | $184.93 | |
| 83735 | <1% | 1,867 | $159.01 | |
| 82565 | <1% | 1,897 | $140.72 | |
| 82040 | <1% | 1,854 | $131.27 | |
| 84100 | <1% | 2,370 | $130.93 | |
| 84155 | <1% | 2,559 | $118.89 | |
| 82728 | <1% | 1,044 | $90.95 | |
| J2916 | Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg | <1% | 76 | $82.65 |
| 82947 | <1% | 1,110 | $66.84 | |
| 82108 | <1% | 334 | $47.93 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 173 | $45.97 |
| 84075 | <1% | 839 | $34.57 | |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 30,431 | $20.40 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 197 | $19.20 |
| G0008 | Administration of influenza virus vaccine | <1% | 147 | $17.75 |
| 82607 | <1% | 121 | $13.72 | |
| 82746 | <1% | 129 | $13.38 | |
| 80051 | 0% | 1,828 | $0.00 | |
| 85018 | 0% | 6,297 | $0.00 | |
| 86706 | 0% | 172 | $0.00 | |
| 87340 | 0% | 883 | $0.00 | |
| J3490 | Unclassified drugs | 0% | 820 | $0.00 |
| 86704 | 0% | 22 | $0.00 | |
| 80069 | 0% | 287 | $0.00 | |
| 86803 | 0% | 68 | $0.00 | |
| 90661 | 0% | 18 | $0.00 | |
| 90682 | 0% | 24 | $0.00 | |
| A6216 | Gauze, non-impregnated, non-sterile, pad size 16 sq. in. or less, without adhesive border, each dressing | 0% | 272 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.